In focus
Latest feed
Ultragenyx’s Rare‑Disease Stock Soars After FDA Greenlights First Sanfilippo Gene Therapy
Biotech Breakthroughs Send Roivant and Pharvaris to All‑Time Highs
Biotech Breakthroughs Send Roivant and Pharvaris Stocks to New Peaks
Biotech M&A Fever: Eli Lilly's Bold Bets Spark Retail Trader Excitement for Sellas and ImmunityBio
Latest headlines
